申请人:Wunberg Tobias
公开号:US20110281838A1
公开(公告)日:2011-11-17
The present invention encompasses compounds of general Formula (1) wherein R
1
to R
4
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了通式(1)中定义为权利要求1中所述的R1至R4的化合物,这些化合物适用于治疗由过度或异常细胞增殖所特征的疾病,并且可以用于制备具有上述特性的药物。